Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01885299 · ClinicalTrials.gov registry record
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
A clinical trial of Neoplasms and Trigeminal Neuralgia, sponsored by The Radiosurgery Society.
- Recruiting
- Registry status
- 50,000
- Enrollment target
- 13
- Study locations
NCT01885299 is a study of Neoplasms and Trigeminal Neuralgia that is actively recruiting participants, run by The Radiosurgery Society. The registered enrollment target is 50,000 participants, above the 1,305-participant average among 158 other Neoplasms trials with a reported enrollment target (3731% higher). The trial reports 13 study locations across 9 states.
The verdict
NCT01885299, a study of Neoplasms and Trigeminal Neuralgia, is actively recruiting participants, sponsored by The Radiosurgery Society.
- RECRUITING
- Registry status
- 50,000 participants
- Enrollment target
- 13
- Study locations
Study Summary
The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)
Conditions Studied
Interventions
- RADIATION SRS/SBRT
Study Locations (13)
New Jersey
- AtlantiCare Regional Medical Center and AtlantiCare Cancer Care Institute - Egg Harbor
- Riverview Medical Center - Red Bank
- NJ Cyberknife at Community Medical Center - Toms River
Pennsylvania
- Geisinger Health System - Danville
- Philadelphia CyberKnife - Philadelphia
- Pottstown Memorial Medical Center - Pottstown
Colorado
- Penrose Cancer Center - Colorado Springs
Florida
- Sylvester Comprehensive Cancer Center, University of Miami - Miami
Georgia
- Southeast Georgia Health System - Brunswick
Michigan
- Henry Ford Health System - Detroit
New York
- Montefiore Medical Center - The Bronx
Tennessee
- Cyberknife at Erlanger - Chattanooga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2012-03 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01885299
The ClinicalTrials.gov registry entry for NCT01885299 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,305-participant average among 158 other Neoplasms trials with a reported enrollment target (3731% higher). The listed sponsor is The Radiosurgery Society, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which SRS/SBRT is the first listed.
NCT01885299 reports 13 study locations spanning 9 distinct geographic areas - top geographies include New Jersey, Pennsylvania, Colorado.
Frequently Asked Questions
What is clinical trial NCT01885299 about?
NCT01885299 is a clinical study titled "RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT". The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with...
What is the current status of trial NCT01885299?
This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2012-03. Estimated completion is 2030-12.
What conditions does trial NCT01885299 study?
This clinical trial studies the following conditions: Neoplasms, Trigeminal Neuralgia, Arteriovenous Malformation of Central Nervous System.
What interventions are being tested in trial NCT01885299?
The interventions under investigation include: SRS/SBRT (RADIATION).
Who is sponsoring clinical trial NCT01885299?
This trial is sponsored by The Radiosurgery Society, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01885299 being conducted?
This trial has 13 study locations across Colorado, Florida, Georgia, Michigan, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RECRUITING · Phase 1
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
RECRUITING · Phase 1
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
RECRUITING · Phase 1
-
Resilience in East Asian Immigrants for Advance Care Planning Discussions
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.